指引出版機構

世界衛生組織(WHO)的臨床指引

World Health Organization

聯合國負責國際公共衛生的專門機構,發布全球適用的臨床、檢驗與公共衛生指引。平台收錄 90 份,用於 31 個科別、77 個學習主題。

用到這些指引的科別

WHO 的指引(90)

依出版年份排列(新到舊)。著作權屬各原權利人;本站不提供全文。

  1. IARC Working Group Report No.12 — Population-Based Helicobacter pylori Screen-and-Treat Strategies for Gastric Cancer Prevention|IARC-WHO|2025
  2. International travel and health — Module 4: Vaccine-preventable diseases and vaccines|WHO|2025
  3. WHO Global Traditional Medicine Strategy 2025–2034|WHO|2025
  4. Application of the essential public health functions: an integrated and comprehensive approach to public health|WHO|2024
  5. Guidelines for the Management of Asymptomatic Sexually Transmitted Infections|WHO|2024
  6. Integration of Traditional, Complementary and Integrative Medicine into Health Systems: Conceptual Framework|WHO|2024
  7. International travel and health — Module 1: General health risks and considerations for travellers|WHO|2024
  8. International travel and health — Module 2: Environmental health risks|WHO|2024
  9. International travel and health — Module 3: Malaria|WHO|2024
  10. WHO clinical treatment guideline for tobacco cessation in adults|WHO|2024
  11. Early Warning Alert and Response in Emergencies: an operational guide|WHO/UNHCR|2023
  12. Heated tobacco products: summary of research and evidence of health impacts|WHO|2023
  13. Laboratory and Point-of-Care Diagnostic Testing for Sexually Transmitted Infections, Including HIV|WHO|2023
  14. WHO Guideline for complementary feeding of infants and young children 6–23 months of age|WHO|2023
  15. WHO report on the global tobacco epidemic 2023|WHO + WHO WPRO|2023
  16. A short guide to cancer screening: Increase effectiveness, maximize benefits and minimize harm|WHO/IARC|2022
  17. Global Report on Assistive Technology|WHO 全球|2022
  18. Human papillomavirus vaccines: WHO position paper (2022 update)|WHO|2022
  19. Manual for selection of molecular WHO-recommended rapid diagnostic tests for detection of tuberculosis and drug-resistant tuberculosis|WHO|2022
  20. Updated Appendix 3 of the WHO Global NCD Action Plan 2013–2030|WHO|2022(2023 背書)
  21. WHO Global Genomic Surveillance Strategy for Pathogens with Pandemic and Epidemic Potential 2022–2032|WHO|2022
  22. WHO consolidated guidelines on tuberculosis — Module 4: Treatment|WHO|2022
  23. WHO consolidated guidelines on tuberculosis, Module 5: Management of TB in children and adolescents|WHO 整合|2022
  24. WHO consolidated guidelines on tuberculosis, Module 5: Management of tuberculosis in children and adolescents|WHO 整合|2022
  25. WHO international standard terminologies on traditional Chinese medicine|WHO|2022
  26. WHO recommendations for care of the preterm or low-birth-weight infant|WHO|2022
  27. Consolidated guidelines on HIV prevention, testing, treatment, service delivery and monitoring|WHO 整合|2021
  28. Genomic sequencing of SARS-CoV-2: a guide to implementation for maximum impact on public health|WHO|2021
  29. Key Technical Issues of Herbal Medicines with Reference to Interaction with Other Medicines(85p,CYP×122/P-gp×28/warfarin×50)|WHO|2021
  30. Social isolation and loneliness among older people(advocacy brief)|WHO 倡議簡報|2021
  31. WHO laboratory manual for the examination and processing of human semen, Sixth Edition|WHO 手冊|2021
  32. Diagnostic testing for SARS-CoV-2: interim guidance|WHO|2020
  33. Immunization Agenda 2030: A Global Strategy to Leave No One Behind|WHO|2020
  34. Laboratory Biosafety Manual, Fourth Edition|WHO|2020
  35. WHO Benchmarks for the Practice of Acupuncture|WHO|2020
  36. World Health Organization 2020 guidelines on physical activity and sedentary behaviour|WHO|2020
  37. Antimicrobial Stewardship Programmes in Health-Care Facilities in Low- and Middle-Income Countries: A WHO Practical Toolkit|WHO|2019
  38. IARC Handbooks of Cancer Prevention, Volume 17: Colorectal Cancer Screening(Section 2: Availability and Use of Colorectal Cancer Screening)|IARC/WHO|2019
  39. Medication Safety in High-risk Situations: Technical Report|WHO|2019
  40. Medication Safety in Transitions of Care: Technical Report|WHO|2019
  41. The SAFER technical package: five areas of intervention at national and subnational levels|WHO|2019
  42. Global Guidelines for the Prevention of Surgical Site Infection, 2nd edition|WHO|2018
  43. Integrating palliative care and symptom relief into primary health care: a WHO guide for planners, implementers and managers|WHO|2018
  44. WHO Expert Consultation on Rabies, third report (WHO Technical Report Series 1012)|WHO|2018
  45. WHO Guidelines for the pharmacological and radiotherapeutic management of cancer pain in adults and adolescents|WHO|2018
  46. Integrated care for older people (ICOPE): Guidelines on community-level interventions to manage declines in intrinsic capacity|WHO ICOPE|2017
  47. Medication Without Harm — WHO Global Patient Safety Challenge|WHO|2017
  48. Responding to children and adolescents who have been sexually abused: WHO clinical guidelines|WHO|2017
  49. WHO Community Engagement Framework for Quality, People-Centred and Resilient Health Services|WHO|2017
  50. WHO Guidelines on Hepatitis B and C Testing|WHO|2017
  51. Electronic Nicotine Delivery Systems and Electronic Non-Nicotine Delivery Systems (ENDS/ENNDS)|WHO FCTC|2016
  52. Establishment of PCR Laboratory in Developing Countries, 2nd edition|WHO|2016
  53. Guidelines on Core Components of Infection Prevention and Control Programmes|WHO|2016
  54. International Health Regulations (2005), Third Edition|WHO|2016(3rd ed)
  55. Malaria Microscopy Quality Assurance Manual, Version 2|WHO|2016
  56. WHO recommendations on antenatal care for a positive pregnancy experience|WHO|2016
  57. Immunization in Practice: A practical guide for health staff, 2015 update|WHO|2015
  58. Medical Eligibility Criteria for Contraceptive Use, 5th edition|WHO|2015
  59. Community Management of Opioid Overdose|WHO|2014
  60. Evidence Brief: How large pictorial health warnings on the packaging of tobacco products affect knowledge and behaviour|WHO Regional Office for Europe|2014
  61. Health care for women subjected to IPV or sexual violence: a clinical handbook|WHO|2014
  62. Health in All Policies: Helsinki Statement. Framework for Country Action|WHO/Finland Ministry of Social Affairs and Health|2014
  63. Reporting and learning systems for medication errors: the role of pharmacovigilance centres|WHO|2014
  64. The High 5s Project: Interim Report|WHO|2014
  65. WHO handbook for guideline development, 2nd ed.|WHO|2014
  66. Correlates of Vaccine-Induced Protection: Methods and Implications (WHO/IVB/13.01)|WHO|2013
  67. Pocket Book of Hospital Care for Children (2nd ed.) — Chapter 4: Cough or Difficulty in Breathing|WHO|2013
  68. Responding to intimate partner violence and sexual violence against women: WHO clinical and policy guidelines|WHO|2013
  69. WHO recommendations for the prevention and management of tobacco use and second-hand smoke exposure in pregnancy|WHO|2013
  70. Review of areca (betel) nut and tobacco use in the Pacific: a technical report|WHO Regional Office for the Western Pacific|2012
  71. A Guide to Clinical Management and Public Health Response for Hand, Foot and Mouth Disease (HFMD)|WHO|2011
  72. Laboratory Quality Management System: Handbook|WHO|2011
  73. Benchmarks for training in traditional Chinese medicine|WHO|2010
  74. Framework for Action on Interprofessional Education & Collaborative Practice|WHO|2010
  75. Global estimate of the burden of disease from second-hand smoke|WHO|2010
  76. Use of Influenza Rapid Diagnostic Tests|WHO|2010
  77. WHO Healthy Workplace Framework and Model: Background and Supporting Literature and Practices|WHO|2010
  78. WHO Model Formulary for Children|WHO|2010
  79. Guidelines for the Psychosocially Assisted Pharmacological Treatment of Opioid Dependence|WHO|2009
  80. Laboratory Guidelines for Enumerating CD4 T Lymphocytes in the Context of HIV/AIDS|WHO|2009
  81. WHO Guidelines on Hand Hygiene in Health Care|WHO|2009
  82. Closing the Gap in a Generation: Health Equity through Action on the Social Determinants of Health|WHO 社會決定因素委員會|2008
  83. WHO Standard Acupuncture Point Locations in the Western Pacific Region|WHO WPRO|2008
  84. Mass Casualty Management Systems: Strategies and Guidelines for Building Health Sector Capacity|WHO|2007
  85. WHO Guidelines on Safety Monitoring of Herbal Medicines in Pharmacovigilance Systems|WHO|2004
  86. WHO General Guidelines for Methodologies on Research and Evaluation of Traditional Medicine|WHO|2000
  87. WHO Guidelines on Basic Training and Safety in Acupuncture(WHO/EDM/TRM/99.1)|WHO|1999
  88. WHO Recommended Surveillance Standards, Second edition|WHO|1999
  89. Thermal Protection of the Newborn: A Practical Guide (WHO/RHT/MSM/97.2)|WHO|1997
  90. Needle and Syringe Programmes for People Who Inject Drugs — Operational Guide|WHO|—

其他出版機構

全部機構 › 新版指引與共識 ›

使用 Google 帳號登入,第一次登入時選擇科別即可開始;已經在用?直接登入